Blockbuster health care acquisitions involving two Connecticut insurers could reduce competition in prescription drug pricing and deal a blow to consumers, Iowa’s Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, said as he asked the U.S. Department of Justice to take a closer look at the corporate deals.
Featured News
Michael Burry Accuses Nvidia of Blocking AMD From Key AI Deal
Mar 10, 2026 by
CPI
Meta to Charge Advertisers Fee in EU Markets With Digital Taxes
Mar 10, 2026 by
CPI
German Advertising and Media Groups Urge Antitrust Action Against Apple
Mar 10, 2026 by
CPI
Dutch Appeals Court Upholds Ruling Requiring Chronological Feeds on Facebook and Instagram
Mar 10, 2026 by
CPI
Sony Fights £2 Billion London Lawsuit Over PlayStation Store Prices
Mar 10, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece